Literature DB >> 27436023

Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.

Yoon Seong Choi1, Ho-Joon Lee1, Sung Soo Ahn1, Jong Hee Chang2, Seok-Gu Kang2, Eui Hyun Kim2, Se Hoon Kim3, Seung-Koo Lee4.   

Abstract

OBJECTIVES: To evaluate the ability of the initial area under the curve (IAUC) derived from dynamic contrast-enhanced MR imaging (DCE-MRI) and apparent diffusion coefficient (ADC) in differentiating between primary central nervous system lymphoma (PCNSL) and atypical glioblastoma (GBM).
METHODS: We retrospectively identified 19 patients with atypical GBM (less than 13 % necrosis of the enhancing tumour), and 23 patients with PCNSL. The histogram parameters of IAUC at 30, 60, 90 s (IAUC30, IAUC60, and IAUC90), and ADC were compared between PCNSL and GBM. The diagnostic performances and added values of the IAUC and ADC for differentiating between PCNSL and GBM were evaluated. Interobserver agreement was assessed via intraclass correlation coefficient (ICC).
RESULTS: The IAUC and ADC parameters were higher in GBM than in PCNSL. The 90th percentile (p90) of IAUC30 and 10th percentile (p10) of ADC showed the best diagnostic performance. Adding p90 of IAUC30 to p10 of ADC improved the differentiation between PCNSL and GBM (area under the ROC curve [AUC] = 0.886), compared to IAUC30 or ADC alone (AUC = 0.789 and 0.744; P < 0.05 for all). The ICC was 0.96 for p90 of IAUC30.
CONCLUSIONS: The IAUC may be a useful parameter together with ADC for differentiating between PCNSL and atypical GBM. KEY POINTS: • High reproducibility is essential for practical implementation of advanced MRI parameters. • IAUC and ADC are highly reproducible parameters. • IAUC values were higher in atypical GBM than in PCNSL. • Adding IAUC to ADC improved the differentiation between PCNSL and GBM. • IAUC with ADC are useful for differentiating PCNSL from GBM.

Entities:  

Keywords:  ADC; DCE-MRI; DTI; Glioblastoma; Primary central nervous system lymphoma

Mesh:

Substances:

Year:  2016        PMID: 27436023     DOI: 10.1007/s00330-016-4484-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.

Authors:  Hie Bum Suh; Yoon Seong Choi; Sohi Bae; Sung Soo Ahn; Jong Hee Chang; Seok-Gu Kang; Eui Hyun Kim; Se Hoon Kim; Seung-Koo Lee
Journal:  Eur Radiol       Date:  2018-04-06       Impact factor: 5.315

2.  The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter.

Authors:  Y S Choi; S S Ahn; H-J Lee; J H Chang; S-G Kang; E H Kim; S H Kim; S-K Lee
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-22       Impact factor: 3.825

3.  Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study.

Authors:  J I Traylor; D C A Bastos; D Fuentes; M Muir; R Patel; V A Kumar; R J Stafford; G Rao; S S Prabhu
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-01       Impact factor: 3.825

Review 4.  The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.

Authors:  Weilin Xu; Qun Wang; Anwen Shao; Bainan Xu; Jianmin Zhang
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

5.  Comparative study on different therapies on patients with primary central nervous system lymphoma.

Authors:  Xuchu Yang; Xinfeng Zhang; Huaizhang Wang; Shuochuan Liu; Wenwen Jin; Yingyue Li; Huaimin Liu
Journal:  Saudi J Biol Sci       Date:  2018-11-09       Impact factor: 4.219

6.  The value of whole lesion ADC histogram profiling to differentiate between morphologically indistinguishable ring enhancing lesions-comparison of glioblastomas and brain abscesses.

Authors:  Diana Horvath-Rizea; Alexey Surov; Karl-Titus Hoffmann; Nikita Garnov; Cathrin Vörkel; Patricia Kohlhof-Meinecke; Oliver Ganslandt; Hansjörg Bäzner; Georg Alexander Gihr; Marcell Kalman; Elina Henkes; Hans Henkes; Stefan Schob
Journal:  Oncotarget       Date:  2018-04-06

7.  Apparent diffusion coefficient histogram analysis can evaluate radiation-induced parotid damage and predict late xerostomia degree in nasopharyngeal carcinoma.

Authors:  Nan Zhou; Tingting Guo; Huanhuan Zheng; Xia Pan; Chen Chu; Xin Dou; Ming Li; Song Liu; Lijing Zhu; Baorui Liu; Weibo Chen; Jian He; Jing Yan; Zhengyang Zhou; Xiaofeng Yang
Journal:  Oncotarget       Date:  2017-07-26

Review 8.  Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring.

Authors:  C Chiavazza; A Pellerino; F Ferrio; A Cistaro; R Soffietti; R Rudà
Journal:  Biomed Res Int       Date:  2018-06-21       Impact factor: 3.411

9.  Diagnostic accuracy of dynamic contrast-enhanced perfusion MRI in stratifying gliomas: A systematic review and meta-analysis.

Authors:  Sachi Okuchi; Antonio Rojas-Garcia; Agne Ulyte; Ingeborg Lopez; Jurgita Ušinskienė; Martin Lewis; Sara M Hassanein; Eser Sanverdi; Xavier Golay; Stefanie Thust; Jasmina Panovska-Griffiths; Sotirios Bisdas
Journal:  Cancer Med       Date:  2019-08-07       Impact factor: 4.452

10.  LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.

Authors:  Le Ge; Lixia Xu; Shan Lu; Hua Yan
Journal:  FEBS Open Bio       Date:  2020-04-13       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.